Test Price
2,800 AED✅ Home Collection Available
CPT1C Gene (SPG73) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Next-Generation Sequencing (NGS) processed in ISO 9001:2015 accredited facility.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test clinical correlation session with a DHA-licensed genetics counsellor.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Advanced genetic test for diagnosing Hereditary Spastic Paraplegia Type 73 (SPG73) with 99.9% lab precision, complemented by premium home collection service complying with DHA and UAE data protection laws.
Test Overview & Methodology
The CPT1C Gene (SPG73) Genetic Test screens the entire coding region of the CPT1C gene for pathogenic variants linked to Hereditary Spastic Paraplegia Type 73 (SPG73) – a rare neurological disorder characterized by progressive lower‑limb weakness and spasticity. Using next‑generation sequencing and rigorous bioinformatics, this test delivers definitive molecular diagnosis to guide clinical management and family planning.
| Feature | Our CPT1C NGS Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | Full gene sequencing + copy number analysis | Only targeted mutation hotspot |
| Method | Next‑Generation Sequencing (LC‑MS/MS‑verified) | Sanger sequencing (limited throughput) |
| Turnaround | 3–4 Weeks (expedited available) | 4–6 Weeks |
Physician Insight & Safety Protocols
"The CPT1C gene test is a valuable tool for confirming SPG73, but results must always be correlated with neurological examination and family history. Genetic counselling before and after testing is essential to discuss penetrance, reproductive options, and psychological support. This test enables informed clinical decisions, not a standalone diagnosis."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
🔴 Medication Advisory
Do not discontinue any prescribed medication or supplement without consulting your physician.
Antispasticity drugs (e.g., baclofen, tizanidine) do not require cessation for DNA testing, but please inform our phlebotomist of all current medications.
🚨 Safety Exclusion Criteria & Red Flags
- Acute febrile illness or systemic infection – postpone collection until recovered.
- Inability to provide informed consent – legal guardian must consent for minors per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Severe psychiatric crisis impeding understanding of genetic implications – refer for stabilisation first.
- Recent blood transfusion or allogeneic transplant (within 3 weeks) – may interfere with germline DNA analysis.
- Emergency warning signs: sudden-onset severe weakness, respiratory difficulty, or loss of bladder control after sample collection – seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What sample types are accepted for this genetic test?
The test requires a whole blood sample collected in EDTA, extracted DNA, or a single drop of blood dried on an FTA card. Our VIP mobile phlebotomy team uses the least invasive method suitable for your age and vein condition.
2. How long does it take to get results?
The final result is issued within 3 to 4 weeks from sample receipt at the lab. Expedited reporting is available for urgent consultations upon special request.
3. Does a negative CPT1C result rule out hereditary spastic paraplegia?
A negative CPT1C result excludes only SPG73. Other HSP subtypes (e.g., SPG4, SPG7) or copy‑number variants may still be present. Your neurologist may recommend a multi‑gene panel or whole‑exome sequencing if clinical suspicion remains high.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained and documented as per Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted and stored in UAE-based servers with restricted access.
Clinical & Logistical Metadata
| Test Name | CPT1C Gene (SPG73) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (expedited available) |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) with LC-MS/MS verification |
| ICD-10-CM Code | G11.4 (Hereditary spastic paraplegia) |
| LOINC Code | 21665-5 (Genetic analysis) |
| DHA Facility License & Address | License: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians